when is retatrutide coming out UK Guide: Key Facts on the New Weight-Loss Drug retatrutide what is retatrutide clinical

Evidence for functional nicotinic receptors on pancreatic beta cells

Conflicts of Interest The authors have no conflicts of interest to declare

Weight Loss FAQs Your Weight Loss Journey Heres how your next 3-4 months will be Month 3-4 Kickstart Your Journey Begin your journey with an in-office appointment and weekly visits with a medical provider

The 24.2% weight loss figure represents a meaningful advancement over anything else currently available or in late-stage development

This leads many people to prematurely conclude that retatrutide is not working when, in fact, it is working exactly as designed

In a 48-week phase II clinical trial conducted on patients with type 2 diabetes and obesity, treatment with a dose of 10 mg/kg of bimagrumab resulted in a significant reduction in fat mass by 20.5% (compared to 0.5% in the placebo group), while lean body mass increased by 3.6% (as opposed to a decrease of 0.8% in the placebo group), leading to an overall body weight reduction of -6.5%, which was substantially better than the -0.8% observed in the placebo group